WHO on Thursday has warned for probable spread of Zika virus across the North and Central American countries. Ahead of rising concerns for Zika spreading, drug makers and scientists have commented that manufacturing of an appropriate vaccine may even require a decade. These warnings has opened a huge business potential for Oxitec, an Intrexon subsidiary. Oxitec’s gene modified mosquitoes are capable of ensuring security against Zika for large populations.
Intrexon Corp.
Breaking News
A PricewaterhouseCoopers report revealed that venture capitalist invested around US$320 million into Maryland last quarter.
A biotech company wants to raise US$125 million through its IPO.